In a cross-study comparison with data at months @ and @ from the pharmacokinetic substudy of the A@ trial , in which patients received cyclosporine , mean values for everolimus C@ , Cmax and AUC@-@ were similar to those in the ASSET trial but the everolimus dose needed to achieve similar exposure was @ - to @-fold higher with concomitant tacrolimus versus cyclosporine .